1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
House Bill 2175
Sponsored by Representative HELFRICH (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced.The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act changes drug crime laws related to pill presses and similar equipment. The Act
takes effect on the 91st day after sine die. (Flesch Readability Score: 71.2).
Creates the crime of possessing, purchasing, making, delivering or selling a pill press or similar
equipment. Punishes by a maximum of five years’ imprisonment, a $125,000 fine, or both.
Takes effect on the 91st day following adjournment sine die.
A BILL FOR AN ACT
Relating to controlled substance crimes; creating new provisions; amending ORS 475.916; and pre-
scribing an effective date.
Be It Enacted by the People of the State of Oregon:
SECTION 1. Section 2 of this 2025 Act is added to and made a part of ORS 475.752 to
475.980.
SECTION 2.(1) Except as authorized by a registration under ORS 475.125, it is unlawful
for any person to possess, purchase, make, deliver, sell or possess with intent to sell or de-
liver a tableting machine, an encapsulating machine or controlled substance counterfeiting
materials, knowing, intending or having reasonable cause to believe that the machine or
materials will be used to manufacture a controlled substance or a counterfeit substance.
(2) A violation of subsection (1) of this section is a Class C felony.
(3) When the court sentences a person under this section, the court shall use crime
category 6 of the sentencing guidelines grid of the Oregon Criminal Justice Commission, and
shall determine the sentence by using the criminal history scale of the sentencing guidelines
grid.
(4) As used in this section:
(a) “Controlled substance counterfeiting material” means a punch, die, plate, stone or
other item designed to print, imprint or reproduce the trademark, trade name or other
identifying mark, imprint or device of another or any likeness of any of the foregoing upon
a drug or container or labeling thereof so as to render such drug a counterfeit substance.
(b) “Encapsulating machine” means equipment that can be used to fill shells or capsules
with powdered or granular solids or semisolid material to produce coherent solid contents.
(c) “Tableting machine” means equipment that can be used to compact, compress or
mold powdered or granular solids or semisolid material to produce coherent solid tablets.
SECTION 3. ORS 475.916 is amended to read:
475.916. (1) It is unlawful for any person knowingly or intentionally:
(a) To deliver as a registrant a controlled substance classified in Schedule I or II, except pur-
suant to an order form as required by ORS 475.175;
NOTE:Matter in boldfaced type in an amended section is new; matter [italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 218 HB2175
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
(b) To use in the course of manufacture or delivery of a controlled substance a registration
number which is fictitious, revoked, suspended or issued to another person;
(c) To acquire or to attempt to acquire or obtain or attempt to obtain possession of a controlled
substance by misrepresentation, fraud, forgery, deception or subterfuge; or
(d) To furnish false or fraudulent material information in, or omit any material information from,
any application, report, record or other document required to be kept or filed under ORS 475.005 to
475.285 and 475.752 to 475.980.[; or]
[(e) To make, deliver or possess any punch, die, plate, stone or other thing designed to print, im-
print or reproduce the trademark, trade name or other identifying mark, imprint or device of another
or any likeness of any of the foregoing upon any drug or container or labeling thereof so as to render
the drug a counterfeit substance.]
(2) Any person who violates this section is guilty of a Class A misdemeanor.
SECTION 4. This 2025 Act takes effect on the 91st day after the date on which the 2025
regular session of the Eighty-third Legislative Assembly adjourns sine die.
[2]